Francesco Ceci - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Francesco Ceci

Showing results (81-90 of 148) with videos related to

Pageof 15

Sort By:

Cancers|May 9, 2020

18F-FDG Pet Parameters and Radiomics Features Analysis in Advanced Nsclc Treated with Immunotherapy as Predictors of Therapy Response and SurvivalGiulia Polverari, Francesco Ceci, Valentina Bertaglia, et al.

European Journal of Nuclear Medicine and Molecular Imaging|February 26, 2022

Event-free survival after 68 Ga-PSMA-11 PET/CT in recurrent hormone-sensitive prostate cancer (HSPC) patients eligible for salvage therapyFrancesco Ceci, Guido Rovera, Giuseppe Carlo Iorio, et al.

Hematological Oncology|May 20, 2023

[18 F]-FDG PET radiomic model as prognostic biomarker in diffuse large B-cell lymphomaLaura Lavinia Travaini, Francesca Botta, Enrico Derenzini, et al.

International Journal of Urology : Official Journal of the Japanese Urological Association|May 15, 2019

How does 68 Ga-prostate-specific membrane antigen positron emission tomography/computed tomography impact the management of patients with prostate cancer recurrence after surgery?Lorenzo Bianchi, Riccardo Schiavina, Marco Borghesi, et al.

European Journal of Nuclear Medicine and Molecular Imaging|March 18, 2022

Correction to: Unconventional non-amino acidic PET radiotracers for molecular imaging in gliomasR Laudicella, N Quartuccio, G Argiroffi, et al.

European Journal of Nuclear Medicine and Molecular Imaging|April 14, 2021

Unconventional non-amino acidic PET radiotracers for molecular imaging in gliomasR Laudicella, N Quartuccio, G Argiroffi, et al.

Archivos Espanoles De Urologia|May 8, 2015

State of the art of PET/CT with 11-choline and 18F-fluorocholine in the diagnosis and follow-up of localized and locally advanced prostate cancerValerio Vagnoni, Eugenio Brunocilla, Lorenzo Bianchi, et al.

European Journal of Nuclear Medicine and Molecular Imaging|April 22, 2020

68Ga-PSMA-11 PET/CT in recurrent hormone-sensitive prostate cancer (HSPC): a prospective single-centre study in patients eligible for salvage therapyDésirée Deandreis, Alessia Guarneri, Francesco Ceci, et al.

The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|June 11, 2024

New target therapies in prostate cancer: from radioligand therapy, to PARP-inhibitors and immunotherapyFrancesco Ceci, Lighea S Airò Farulla, Elena Bonatto, et al.

European Journal of Nuclear Medicine and Molecular Imaging|February 20, 2024

First-in-human validation of a DROP-IN β-probe for robotic radioguided surgery: defining optimal signal-to-background discrimination algorithmFrancesco Collamati, Silvio Morganti, Matthias N van Oosterom, et al.

Pageof 15

Search research articles

Showing results (81-90 of 148) with videos related to